CREBBP/EP300 Mutation Is Associated With Poor Outcome in HNSCC and Targetable With Synthetic Cytotoxicity.
doi 10.1101/2020.04.10.028217
Full Text
Open PDFAbstract
Available in full text
Date
April 11, 2020
Authors
Publisher
Cold Spring Harbor Laboratory